Morgan Stanley lowered the firm’s price target on Xerox to $12 from $13 and keeps an Underweight rating on the shares after the company missed Q3 revenue and margin expectations and guided down calendar 2023 revenue to the low end of their guidance range. While the new “Xerox Reinvention” plan is intended to drive considerable operating leverage in the model, the firm is “skeptical” and calls Xerox “a show-me story.”
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on XRX:
